Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Hypertension

  Free Subscription


Articles published in Circulation

Retrieve available abstracts of 181 articles:
HTML format



Single Articles


    April 2021
  1. BRYANT KB, Moran AE, Kazi DS, Zhang Y, et al
    Cost-effectiveness of Hypertension Treatment by Pharmacists in Black Barbershops.
    Circulation. 2021 Apr 15. doi: 10.1161/CIRCULATIONAHA.120.051683.
    PubMed     Abstract available


  2. HOWDEN EJ, Ruiz-Carmona S, Claeys M, de Bosscher R, et al
    Oxygen Pathway Limitations in Patients with Chronic Thromboembolic Pulmonary Hypertension.
    Circulation. 2021 Apr 15. doi: 10.1161/CIRCULATIONAHA.120.052899.
    PubMed     Abstract available


    March 2021
  3. LI D, Shao NY, Moonen JR, Zhao Z, et al
    ALDH1A3 Coordinates Metabolism with Gene Regulation in Pulmonary Arterial Hypertension.
    Circulation. 2021 Mar 25. doi: 10.1161/CIRCULATIONAHA.120.048845.
    PubMed     Abstract available


  4. ZHU L, Liu F, Hao Q, Feng T, et al
    Dietary Geranylgeranyl Pyrophosphate Counteracts the Benefits of Statin Therapy in Experimental Pulmonary Hypertension.
    Circulation. 2021 Mar 4. doi: 10.1161/CIRCULATIONAHA.120.046542.
    PubMed     Abstract available


    February 2021
  5. KUEHN BM
    Rising Prepregnancy Hypertension, Preeclampsia Disparities Raise Alarm.
    Circulation. 2021;143:753-754.
    PubMed    


  6. SUDHARSANAN N, Theilmann M, Kirschbaum TK, Manne-Goehler J, et al
    Variation in the Proportion of Adults in Need of BP-Lowering Medications by Hypertension Care Guideline in Low- and Middle-Income Countries: A Cross-Sectional Study of 1,037,215 Individuals from 50 Nationally Representative Surveys.
    Circulation. 2021 Feb 8. doi: 10.1161/CIRCULATIONAHA.120.051620.
    PubMed     Abstract available


    January 2021
  7. MCEVOY JW
    Letter by McEvoy Regarding Article, "Cardiovascular Risk of Isolated Systolic or Diastolic Hypertension in Young Adults".
    Circulation. 2021;143:e20-e21.
    PubMed    


  8. LEE H, Yano Y, Cho SMJ, Lloyd-Jones DM, et al
    Response by Lee et al to Letter Regarding Article, "Cardiovascular Risk of Isolated Systolic or Diastolic Hypertension in Young Adults".
    Circulation. 2021;143:e22-e23.
    PubMed    


    December 2020
  9. BOGUSLAVSKYI A, Tokar S, Prysyazhna O, Rudyk O, et al
    Phospholemman Phosphorylation Regulates Vascular Tone, Blood Pressure and Hypertension in Mice and Man.
    Circulation. 2020 Dec 18. doi: 10.1161/CIRCULATIONAHA.119.040557.
    PubMed     Abstract available


    November 2020
  10. SCIRICA BM, Cannon CP, Fisher NDL, Gaziano TA, et al
    Digital Care Transformation: Interim Report From the First 5000 Patients Enrolled in a Remote Algorithm-Based Cardiovascular Risk Management Program to Improve Lipid and Hypertension Control.
    Circulation. 2020 Nov 17. doi: 10.1161/CIRCULATIONAHA.120.051913.
    PubMed    


    October 2020

  11. Correction to: Identification of Long Noncoding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial Hypertension.
    Circulation. 2020;142:e235.
    PubMed    


  12. ZHANG DY, Cheng YB, Guo QH, Shan XL, et al
    Treatment of Masked Hypertension with a Chinese Herbal Formula: A Randomized, Placebo-Controlled Trial.
    Circulation. 2020 Oct 6. doi: 10.1161/CIRCULATIONAHA.120.046685.
    PubMed     Abstract available


  13. LACKLAND DT, Howard VJ, Cushman M, Oparil S, et al
    Forty-Year Shifting Distribution of Systolic Blood Pressure With Population Hypertension Treatment and Control.
    Circulation. 2020 Oct 5. doi: 10.1161/CIRCULATIONAHA.120.048063.
    PubMed    


    September 2020
  14. CUI C, Fan J, Zeng Q, Cai J, et al
    CD4(+) T-Cell Endogenous Cystathionine gamma Lyase-Hydrogen Sulfide Attenuates Hypertension by Sulfhydrating Liver Kinase B1 to Promote T Regulatory Cell Differentiation and Proliferation.
    Circulation. 2020 Sep 9. doi: 10.1161/CIRCULATIONAHA.119.045344.
    PubMed     Abstract available


    August 2020
  15. HONIGBERG MC, Chaffin M, Aragam K, Bhatt DL, et al
    Genetic Variation in Cardiometabolic Traits and Medication Targets and the Risk of Hypertensive Disorders of Pregnancy.
    Circulation. 2020;142:711-713.
    PubMed    


    July 2020
  16. SHEN H, Zhang J, Wang C, Jain PP, et al
    MDM2-Mediated Ubiquitination of ACE2 Contributes to the Development of Pulmonary Arterial Hypertension.
    Circulation. 2020 Jul 28. doi: 10.1161/CIRCULATIONAHA.120.048191.
    PubMed     Abstract available


  17. OMURA J, Habbout K, Shimauchi T, Wu WH, et al
    Identification of The Long Non-Coding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial Hypertension.
    Circulation. 2020 Jul 23. doi: 10.1161/CIRCULATIONAHA.120.047626.
    PubMed     Abstract available


  18. GUO C, Zeng Y, Chang LY, Yu Z, et al
    Independent and Opposing Associations of Habitual Exercise and Chronic PM2.5 Exposures on Hypertension Incidence.
    Circulation. 2020 Jul 20. doi: 10.1161/CIRCULATIONAHA.120.045915.
    PubMed    


  19. HAYNES N, Cooper LA, Albert MA
    At the Heart of the Matter: Unmasking and Addressing the Toll of COVID-19 on Diverse Populations.
    Circulation. 2020;142:105-107.
    PubMed    


    June 2020
  20. MESSERLI FH, Siontis GCM, Rexhaj E
    COVID-19 and Renin Angiotensin Blockers: Current Evidence and Recommendations.
    Circulation. 2020;141:2042-2044.
    PubMed    


  21. ERCU M, Marko L, Schachterle C, Tsvetkov D, et al
    Phosphodiesterase 3A and Arterial Hypertension.
    Circulation. 2020 Jun 11. doi: 10.1161/CIRCULATIONAHA.119.043061.
    PubMed     Abstract available


  22. LEE H, Yano Y, Cho SMJ, Park JH, et al
    Cardiovascular Risk of Isolated Systolic or Diastolic Hypertension in Young Adults.
    Circulation. 2020;141:1778-1786.
    PubMed     Abstract available


    May 2020
  23. HOFFMANN F, Limper U, Zaha VG, Reuter H, et al
    Evolution of Pulmonary Hypertension During Severe Sustained Hypoxia.
    Circulation. 2020;141:1504-1506.
    PubMed    


    April 2020
  24. FULTON DJR, Stepp DW
    Origins of Hypertension in Obesity: Plain Vanilla(oid) or Multiple Flavors?
    Circulation. 2020;141:1334-1337.
    PubMed    


  25. SIEDLINSKI M, Jozefczuk E, Xu X, Teumer A, et al
    White Blood Cells and Blood Pressure: A Mendelian Randomization Study.
    Circulation. 2020;141:1307-1317.
    PubMed     Abstract available


  26. OTTOLINI M, Hong K, Cope EL, Daneva Z, et al
    Local Peroxynitrite Impairs Endothelial Transient Receptor Potential Vanilloid 4 Channels and Elevates Blood Pressure in Obesity.
    Circulation. 2020;141:1318-1333.
    PubMed     Abstract available


  27. FRIED JA, Ramasubbu K, Bhatt R, Topkara VK, et al
    The Variety of Cardiovascular Presentations of COVID-19.
    Circulation. 2020 Apr 3. doi: 10.1161/CIRCULATIONAHA.120.047164.
    PubMed    


    March 2020
  28. WHITE WB, Wolfson L
    Response to Letter Regarding Article, "Effects of Intensive Versus Standard Ambulatory Blood Pressure Control on Cerebrovascular Outcomes in Older People (INFINITY)".
    Circulation. 2020;141:e652-e653.
    PubMed    


  29. RIVASI G, Mossello E, Ungar A
    Letter by Rivasi et al Regarding Article, "Effects of Intensive Versus Standard Ambulatory Blood Pressure Control on Cerebrovascular Outcomes in Older People (INFINITY)".
    Circulation. 2020;141:e650-e651.
    PubMed    


  30. POTUS F, Pauciulo MW, Cook EK, Zhu N, et al
    Novel Mutations and Decreased Expression of the Epigenetic Regulator TET2 in Pulmonary Arterial Hypertension.
    Circulation. 2020 Mar 20. doi: 10.1161/CIRCULATIONAHA.119.044320.
    PubMed     Abstract available


  31. JEFFERSON AL
    Midlife Consequences of Cumulative Blood Pressure Exposure: Importance of a Lifespan Approach.
    Circulation. 2020;141:725-727.
    PubMed    


  32. SCHIMMEL K, Jung M, Foinquinos A, Jose GS, et al
    Natural Compound Library Screening Identifies New Molecules for the Treatment of Cardiac Fibrosis and Diastolic Dysfunction.
    Circulation. 2020;141:751-767.
    PubMed     Abstract available


  33. MAHINRAD S, Kurian S, Garner CR, Sedaghat S, et al
    Cumulative Blood Pressure Exposure During Young Adulthood and Mobility and Cognitive Function in Midlife.
    Circulation. 2020;141:712-724.
    PubMed     Abstract available


    February 2020
  34. KUEHN BM
    Race May Influence Transplant Decision Making in Heart Failure: Studies Also Detail Disparities in Hypertension Diagnosis, Statin Prescribing.
    Circulation. 2020;141:694-695.
    PubMed    


  35. ROSENKRANZ S, Howard LS, Gomberg-Maitland M, Hoeper MM, et al
    Systemic Consequences of Pulmonary Hypertension and Right-Sided Heart Failure.
    Circulation. 2020;141:678-693.
    PubMed     Abstract available


  36. KAYE DM, Shihata W, Jama HA, Tsyganov K, et al
    Deficiency of Prebiotic Fibre and Insufficient Signalling Through Gut Metabolite Sensing Receptors Leads to Cardiovascular Disease.
    Circulation. 2020 Feb 25. doi: 10.1161/CIRCULATIONAHA.119.043081.
    PubMed     Abstract available


  37. JACKEVICIUS CA, Krumholz HM, Chong A, Koh M, et al
    Population Impact of Generic Valsartan Recall.
    Circulation. 2020;141:411-413.
    PubMed    


    January 2020
  38. VALENZUELA PL, Ruilope LM, Lucia A
    Muscling in on Resistant Hypertension.
    Circulation. 2020;141:240-242.
    PubMed    


  39. AGDAMAG AC, Krishnappa D, Benditt DG
    ST-Segment Changes After Loss of Consciousness.
    Circulation. 2020;141:80-82.
    PubMed    


  40. ANDERSEN K, Hallmarker U, James S, Sundstrom J, et al
    Long-Distance Skiing and Incidence of Hypertension: A Cohort Study of 206,889 Participants in a Long-Distance Cross-Country Skiing Event.
    Circulation. 2020 Jan 6. doi: 10.1161/CIRCULATIONAHA.119.042208.
    PubMed     Abstract available


  41. GERGES C, Gerges M, Friewald R, Fesler P, et al
    Microvascular Disease in Chronic Thromboembolic Pulmonary Hypertension: Hemodynamic Phenotyping and Histomorphometric Assessment.
    Circulation. 2020 Jan 3. doi: 10.1161/CIRCULATIONAHA.119.041515.
    PubMed     Abstract available


  42. KONG D, Wan Q, Li J, Zuo S, et al
    DP1 Activation Reverses Age-Related Hypertension via NEDD4L-Mediated T-bet Degradation in T Cells.
    Circulation. 2020 Jan 2. doi: 10.1161/CIRCULATIONAHA.119.042532.
    PubMed     Abstract available


    December 2019
  43. GRANDI SM, Smith GN, Platt RW
    The Relative Contribution of Pregnancy Complications to Cardiovascular Risk Prediction: Are We Getting It Wrong?
    Circulation. 2019;140:1965-1967.
    PubMed    


    November 2019
  44. TONG D, Schiattarella GG, Jiang N, May HI, et al
    Female Sex Is Protective in a Preclinical Model of Heart Failure With Preserved Ejection Fraction.
    Circulation. 2019;140:1769-1771.
    PubMed    


  45. PANDEY A, Patel KV, Vongpatanasin W, Ayers C, et al
    Incorporation of Biomarkers Into Risk Assessment for Allocation of Antihypertensive Medication According to the 2017 ACC/AHA High Blood Pressure Guideline: A Pooled Cohort Analysis.
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.043337.
    PubMed    


    October 2019
  46. PENG J, Vongpatanasin W, Sacharidou A, Kifer D, et al
    Supplementation with the Sialic Acid Precursor N-acetyl-D-Mannosamine Breaks the Link Between Obesity and Hypertension.
    Circulation. 2019 Oct 10. doi: 10.1161/CIRCULATIONAHA.119.043490.
    PubMed     Abstract available



  47. Correction to: Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension).
    Circulation. 2019;140:e718.
    PubMed    


  48. RUOPP NF, Farber HW
    The New World Symposium on Pulmonary Hypertension Guidelines: Should Twenty-One Be the New Twenty-Five?
    Circulation. 2019;140:1134-1136.
    PubMed    


  49. DIAZ R, Tajer C
    Current Status and Future Strategies for Cardiovascular Disease in Argentina.
    Circulation. 2019;140:1137-1139.
    PubMed    


    September 2019
  50. SUPIANO MA, Williamson JD
    New Guidelines and SPRINT Results: Implications for Geriatric Hypertension.
    Circulation. 2019;140:976-978.
    PubMed    


  51. COCKBAIN B, Price LC, Hind M
    Bony Breathlessness: Reversible Pulmonary Hypertension in Melnick-Needles Syndrome Using Noninvasive Ventilation
    Circulation. 2019;140:880-885.
    PubMed    


    August 2019
  52. TIAN W, Jiang X, Sung YK, Shuffle E, et al
    Phenotypically-Silent Bone Morphogenetic Protein Receptor 2 (Bmpr2) Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing The Risk for Neointimal Transformation.
    Circulation. 2019 Aug 29. doi: 10.1161/CIRCULATIONAHA.119.040629.
    PubMed     Abstract available


  53. NAEIJE R, Chin K
    Differentiating Precapillary From Postcapillary Pulmonary Hypertension.
    Circulation. 2019;140:712-714.
    PubMed    


  54. KHIRFAN G, Ahmed MK, Almaaitah S, Almoushref A, et al
    Comparison of Different Methods to Estimate Cardiac Index in Pulmonary Arterial Hypertension.
    Circulation. 2019;140:705-707.
    PubMed    


  55. NADEAU V, Bonnet S, Paulin R
    Letter by Nadeau et al Regarding Article, "Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension".
    Circulation. 2019;140:e286-e287.
    PubMed    


  56. MENDES-FERREIRA P, Manaud G, Perros F
    Response by Mendes-Ferreira et al to Letter Regarding Article, "Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension".
    Circulation. 2019;140:e288-e289.
    PubMed    


    July 2019
  57. STRANDBERG TE
    Blood Pressure in a 100-Year Perspective.
    Circulation. 2019;140:101-102.
    PubMed    


    June 2019
  58. GILL D, Georgakis MK, Koskeridis F, Jiang L, et al
    Use of Genetic Variants Related to Antihypertensive Drugs to Inform on Efficacy and Side Effects.
    Circulation. 2019 Jun 25. doi: 10.1161/CIRCULATIONAHA.118.038814.
    PubMed     Abstract available


  59. OLDE RIKKERT MGM, Fernandes M
    Letter by Olde Rikkert and Fernandes Regarding Article, "Potential Cardiovascular Disease Events Prevented With Adoption of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline".
    Circulation. 2019;139:e1021-e1022.
    PubMed    


  60. RUEDA-OCHOA OL, Rizopoulos D, Kavousi M
    Letter by Rueda-Ochoa et al Regarding Article, "Potential Cardiovascular Disease Events Prevented With Adoption of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline".
    Circulation. 2019;139:e1019-e1020.
    PubMed    


    May 2019
  61. SEPEHRVAND N, Alemayehu W, Dyck GJB, Dyck JRB, et al
    External Validation of the H2F-PEF Model in Diagnosing Patients With Heart Failure and Preserved Ejection Fraction.
    Circulation. 2019;139:2377-2379.
    PubMed    


  62. NYSTROM T, Sartipy U, Contardi A, Lind M, et al
    Glycated Hemoglobin A1c Levels in Type 1 Diabetes Mellitus and Outcomes After Myocardial Infarction.
    Circulation. 2019;139:2380-2382.
    PubMed    


  63. KIM B, Arany Z
    Does Glycine cataBOLAsm Drive Pulmonary Hypertension?
    Circulation. 2019;139:2256-2259.
    PubMed    


    April 2019
  64. JAMERSON KA
    Should Certain Antihyperglycemic Medications Be Preferred Over Antihypertensive Medications for Blood Pressure Control in Special Populations With Diabetes Mellitus?
    Circulation. 2019;139:2110-2112.
    PubMed    


  65. FERDINAND KC, Balavoine F, Besse B, Black HR, et al
    Efficacy and Safety of Firibastat, a First-in-Class Brain Aminopeptidase A Inhibitor, in Hypertensive Overweight Patients of Multiple Ethnic Origins A Phase 2, Open-Label, Multicenter, Dose-Titrating Study.
    Circulation. 2019 Apr 24. doi: 10.1161/CIRCULATIONAHA.119.040070.
    PubMed     Abstract available


  66. MARON BA, Ryan JJ
    A Concerning Trend for Patients With Pulmonary Hypertension in the Era of Evidence-Based Medicine.
    Circulation. 2019;139:1861-1864.
    PubMed    


  67. CHIN KM, Rubin LJ, Channick R, Di Scala L, et al
    Association of NT-proBNP and Long-Term Outcome in Patients with Pulmonary Arterial Hypertension: Insights from the Phase III GRIPHON Study.
    Circulation. 2019 Apr 15. doi: 10.1161/CIRCULATIONAHA.118.039360.
    PubMed     Abstract available


  68. WRIGHT AK, Kontopantelis E, Emsley R, Buchan IE, et al
    Cardiovascular Risk and Risk Factor Management in Type 2 Diabetes: A Population-Based Cohort Study Assessing Sex Disparities.
    Circulation. 2019 Apr 15. doi: 10.1161/CIRCULATIONAHA.118.039100.
    PubMed     Abstract available


  69. ZHAO D, Post WS, Blasco-Colmenares E, Cheng A, et al
    Racial Differences in Sudden Cardiac Death.
    Circulation. 2019;139:1688-1697.
    PubMed     Abstract available


    March 2019
  70. AZIZI M, Schmieder RE, Mahfoud F, Weber MA, et al
    Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control Following Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedure in the RADIANCE-HTN SOLO Trial.
    Circulation. 2019 Mar 17. doi: 10.1161/CIRCULATIONAHA.119.040451.
    PubMed     Abstract available


  71. COVASSIN N, Somers VK
    From Resistant Airway to Resistant Hypertension.
    Circulation. 2019;139:1285-1288.
    PubMed    


  72. JOHNSON DA, Thomas SJ, Abdalla M, Guo N, et al
    Association Between Sleep Apnea and Blood Pressure Control Among Blacks.
    Circulation. 2019;139:1275-1284.
    PubMed     Abstract available


    February 2019
  73. FERDINAND KC, Izzo JL, Lee J, Meng L, et al
    Antihyperglycemic and Blood Pressure Effects of Empagliflozin in African Americans with Type 2 Diabetes and Hypertension.
    Circulation. 2019 Feb 21. doi: 10.1161/CIRCULATIONAHA.118.036568.
    PubMed     Abstract available


  74. PETERS SAE, Muntner P, Woodward M
    Sex Differences in the Prevalence of, and Trends in, Cardiovascular Risk Factors, Treatment, and Control in the United States, 2001 to 2016.
    Circulation. 2019;139:1025-1035.
    PubMed     Abstract available


  75. YU Q, Tai YY, Tang Y, Zhao J, et al
    BOLA3 Deficiency Controls Endothelial Metabolism and Glycine Homeostasis in Pulmonary Hypertension.
    Circulation. 2019 Feb 14. doi: 10.1161/CIRCULATIONAHA.118.035889.
    PubMed     Abstract available


    January 2019
  76. BENJAMIN EJ, Muntner P, Alonso A, Bittencourt MS, et al
    Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.
    Circulation. 2019 Jan 31:CIR0000000000000659. doi: 10.1161/CIR.0000000000000659.
    PubMed    


  77. SCHOMBURG L, Melander O
    Letter by Schomburg and Melander Regarding Article, "Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: A Possible Novel Therapeutic Target".
    Circulation. 2019;139:722-723.
    PubMed    


  78. KIKUCHI N, Satoh K, Saito Y, Shimokawa H, et al
    Response by Kikuchi et al Regarding Article, "Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: A Possible Novel Therapeutic Target".
    Circulation. 2019;139:724-725.
    PubMed    


  79. RAM CVS
    Status of Renal Denervation Therapy for Hypertension.
    Circulation. 2019;139:601-603.
    PubMed    



  80. Correction to: Letter by Yang et al Regarding Article, "Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension)".
    Circulation. 2019;139:e3.
    PubMed    



  81. Correction to: Metabolic Reprogramming Regulates the Proliferative and Inflammatory Phenotype of Adventitial Fibroblasts in Pulmonary Hypertension Through the Transcriptional Corepressor C-Terminal Binding Protein-1.
    Circulation. 2019;139:e1.
    PubMed    


  82. FERDINAND KC, Graham RM
    Uncontrolled Hypertension in Black Men.
    Circulation. 2019;139:20-23.
    PubMed    


  83. VICTOR RG, Blyler CA, Li N, Lynch K, et al
    Sustainability of Blood Pressure Reduction in Black Barbershops.
    Circulation. 2019;139:10-19.
    PubMed     Abstract available


  84. BRESS AP, Colantonio LD, Cooper RS, Kramer H, et al
    Potential Cardiovascular Disease Events Prevented with Adoption of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline.
    Circulation. 2019;139:24-36.
    PubMed     Abstract available


    December 2018
  85. YUAN K, Shamskhou EA, Orcholski ME, Nathan A, et al
    Loss of Endothelial Derived WNT5A is Associated with Reduced Pericyte Recruitment and Small Vessel Loss in Pulmonary Arterial Hypertension.
    Circulation. 2018 Dec 11. doi: 10.1161/CIRCULATIONAHA.118.037642.
    PubMed     Abstract available


  86. BARTOLOMAEUS H, Balogh A, Yakoub M, Homann S, et al
    The Short-Chain Fatty Acid Propionate Protects from Hypertensive Cardiovascular Damage.
    Circulation. 2018 Dec 4. doi: 10.1161/CIRCULATIONAHA.118.036652.
    PubMed     Abstract available


    November 2018
  87. KARIO K, Okada K, Kato M, Nishizawa M, et al
    24-Hour Blood Pressure-Lowering Effect of an SGLT-2 Inhibitor in Patients with Diabetes and Uncontrolled Nocturnal Hypertension: Results from the Randomized, Placebo-Controlled SACRA Study.
    Circulation. 2018 Nov 29. doi: 10.1161/CIRCULATIONAHA.118.037076.
    PubMed     Abstract available


  88. KIM HC, Jeon YW, Heo ST
    Global Impact of the 2017 American College of Cardiology/American Heart Association Hypertension Guidelines.
    Circulation. 2018;138:2312-2314.
    PubMed    


    October 2018
  89. FUDIM M, Jones WS
    New Curveball for Hypertension Guidelines?
    Circulation. 2018;138:1815-1818.
    PubMed    


  90. WRIGHT JT JR, Carey RM, Bolen SD
    First-Year Anniversary of the 2017 Hypertension Guideline.
    Circulation. 2018;138:1774-1776.
    PubMed    


  91. BAI G, Bennet C, Wang J, Anderson GF, et al
    Access to Antihypertensive Drugs in China.
    Circulation. 2018;138:1777-1779.
    PubMed    


  92. KHERA A, Budoff MJ, O'Donnell CJ, Ayers CA, et al
    Astronaut Cardiovascular Health and Risk Modification (Astro-CHARM) Coronary Calcium Atherosclerotic Cardiovascular Disease Risk Calculator.
    Circulation. 2018;138:1819-1827.
    PubMed     Abstract available


  93. HAUTEFORT A, Mendes-Ferreira P, Sabourin J, Manaud G, et al
    Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension.
    Circulation. 2018 Oct 4. doi: 10.1161/CIRCULATIONAHA.118.033744.
    PubMed     Abstract available


  94. YANG X, Zhang R, Wang D
    Letter by Yang et al Regarding Article, "Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension)".
    Circulation. 2018;138:1488-1489.
    PubMed    


  95. SCHIAVON CA, Ikeoka D, Santucci EV, Santos RN, et al
    Response by Schiavon et al to Letters Regarding Article, "Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension)".
    Circulation. 2018;138:1492-1493.
    PubMed    


  96. MORIS D, Cerullo M, Guerron AD
    Letter by Moris et al Regarding Article, "Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension)".
    Circulation. 2018;138:1490-1491.
    PubMed    


  97. MARQUES FZ
    Missing Heritability of Hypertension and Our Microbiome.
    Circulation. 2018;138:1381-1383.
    PubMed    


    September 2018
  98. FENGLER K, Rommel KP, Blazek S, Besler C, et al
    A Three-Arm Randomized Trial of Different Renal Denervation Devices and Techniques in Patients with Resistant Hypertension (RADIOSOUND-HTN).
    Circulation. 2018 Sep 25. doi: 10.1161/CIRCULATIONAHA.118.037654.
    PubMed     Abstract available


    August 2018
  99. BONNET S, Paulin R, Boucherat O
    Small SeP or Giant Leap for Pulmonary Hypertension Research?
    Circulation. 2018;138:624-626.
    PubMed    


    May 2018
  100. HADINNAPOLA C, Graf S, Morrell NW
    Response by Hadinnapola et al to Letter Regarding Article, "Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension".
    Circulation. 2018;137:2413-2414.
    PubMed    


  101. HERNANDEZ-GONZALEZ I, Navas P, Escribano-Subias P
    Letter by Hernandez-Gonzalez et al Regarding Article, "Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension".
    Circulation. 2018;137:2411-2412.
    PubMed    


  102. WHITE RJ, Wilkins MR
    New Therapeutic Approaches in Pulmonary Arterial Hypertension: The Pantheon Is Getting Crowded.
    Circulation. 2018;137:2390-2392.
    PubMed    


  103. CAMPBELL NRC, Zhang XH
    Hypertension in China: Time to Transition From Knowing the Problem to Implementing the Solution.
    Circulation. 2018;137:2357-2359.
    PubMed    


  104. REDDY YNV, Carter RE, Obokata M, Redfield MM, et al
    A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure with Preserved Ejection Fraction.
    Circulation. 2018 May 23. pii: CIRCULATIONAHA.118.034646.
    PubMed     Abstract available


  105. MENDY A
    Association of Urinary Nitrate With Lower Prevalence of Hypertension and Stroke and With Reduced Risk of Cardiovascular Mortality.
    Circulation. 2018;137:2295-2297.
    PubMed    


    April 2018
  106. DE LA SIERRA A, Banegas JR, Vinyoles E, Segura J, et al
    Prevalence of Masked Hypertension in Untreated and Treated Patients With Office Blood Pressure Below 130/80 mm Hg.
    Circulation. 2018 Apr 30. pii: CIRCULATIONAHA.118.034619.
    PubMed     Abstract available


  107. LEOPOLD JA
    Pulmonary Venous Remodeling in Pulmonary Hypertension: The Veins Take Center Stage.
    Circulation. 2018;137:1811-1813.
    PubMed    


  108. KIKUCHI N, Satoh K, Kurosawa R, Yaoita N, et al
    Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: A Possible Novel Therapeutic Target.
    Circulation. 2018 Apr 10. pii: CIRCULATIONAHA.117.033113.
    PubMed     Abstract available


    March 2018
  109. SOLIMAN EZ, Ambrosius WT, Lewis CE
    Response by Soliman et al to Letters Regarding Article, "Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial)".
    Circulation. 2018;137:1300-1301.
    PubMed    


  110. JIN-SHAN H, Xue-Bin L
    Letter by Jin-shan and Xue-bin Regarding Article, "Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial)".
    Circulation. 2018;137:1299.
    PubMed    


  111. LEWIS GA, Schelbert EB, Miller CA
    Letter by Lewis et al Regarding Article, "Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial)".
    Circulation. 2018;137:1297-1298.
    PubMed    


  112. TURER CB, Brady TM, de Ferranti SD
    Obesity, Hypertension, and Dyslipidemia in Childhood Are Key Modifiable Antecedents of Adult Cardiovascular Disease: A Call to Action.
    Circulation. 2018;137:1256-1259.
    PubMed    


  113. AUBDOOL AA, Argunhan F, Thakore P, Brain SD, et al
    Response by Aubdool et al to Letters Regarding Article, "A Novel alpha-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure".
    Circulation. 2018;137:1201-1202.
    PubMed    


  114. JIN-SHAN H, Xue-Bin L
    Letter by Jin-shan and Xue-bin Regarding Article, "A Novel alpha-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure".
    Circulation. 2018;137:1200.
    PubMed    


  115. TSUDA K
    Letter by Tsuda Regarding Article, "A Novel alpha-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure".
    Circulation. 2018;137:1198-1199.
    PubMed    


  116. NADRUZ W JR, Claggett B, Henglin M, Shah AM, et al
    Widening Racial Differences in Risks for Coronary Heart Disease.
    Circulation. 2018;137:1195-1197.
    PubMed    


    February 2018
  117. HEMNES AR, Brittain EL
    Autonomic Nervous System in Pulmonary Arterial Hypertension: Time to Rest and Digest.
    Circulation. 2018;137:925-927.
    PubMed    


  118. MANCIA G, Corrao G
    Global Impact of the 2017 American College of Cardiology/American Heart Association Hypertension Guidelines: A Perspective From Italy.
    Circulation. 2018;137:889-890.
    PubMed    


  119. BRUNSTROM M, Carlberg B, Lindholm LH
    Perspective From Sweden on the Global Impact of the 2017 American College of Cardiology/American Heart Association Hypertension Guidelines: A "Sprint" Beyond Evidence in the United States.
    Circulation. 2018;137:886-888.
    PubMed    


  120. SCHIFFRIN EL
    Global Impact of the 2017 American College of Cardiology/American Heart Association Hypertension Guidelines: A Perspective From Canada.
    Circulation. 2018;137:883-885.
    PubMed    


  121. WANG Z, Chen Z, Zhang L, Wang X, et al
    Status of Hypertension in China: Results from the China Hypertension Survey, 2012-2015.
    Circulation. 2018 Feb 15. pii: CIRCULATIONAHA.117.032380.
    PubMed     Abstract available


  122. DUMAS SJ, Bru-Mercier G, Courboulin A, Quatredeniers M, et al
    NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.
    Circulation. 2018 Feb 14. pii: CIRCULATIONAHA.117.029930.
    PubMed     Abstract available


  123. RUBIN LJ
    Assessing Prognosis of Pulmonary Arterial Hypertension in the Therapeutic Era: Importance of Serial Hemodynamic Measurements.
    Circulation. 2018;137:705-706.
    PubMed    


  124. COOPER R
    Hypertension, Genes, and Environment: Challenges for Prevention and Risk Prediction.
    Circulation. 2018;137:662-664.
    PubMed    


  125. WANDER GS, Ram CVS
    Global Impact of 2017 American Heart Association/American College of Cardiology Hypertension Guidelines: A Perspective From India.
    Circulation. 2018;137:549-550.
    PubMed    


  126. WANG JG, Liu L
    Global Impact of 2017 American College of Cardiology/American Heart Association Hypertension Guidelines: A Perspective From China.
    Circulation. 2018;137:546-548.
    PubMed    


  127. KARIO K
    Global Impact of 2017 American Heart Association/American College of Cardiology Hypertension Guidelines: A Perspective From Japan.
    Circulation. 2018;137:543-545.
    PubMed    


  128. CHEN KH, Dasgupta A, Lin J, Potus F, et al
    Epigenetic Dysregulation of the Drp1 Binding Partners MiD49 and MiD51 Increases Mitotic Mitochondrial Fission and Promotes Pulmonary Arterial Hypertension: Mechanistic and Therapeutic Implications.
    Circulation. 2018 Feb 5. pii: CIRCULATIONAHA.117.031258.
    PubMed     Abstract available


    January 2018
  129. SUGLIA SF, Koenen KC, Boynton-Jarrett R, Chan PS, et al
    Childhood and Adolescent Adversity and Cardiometabolic Outcomes: A Scientific Statement From the American Heart Association.
    Circulation. 2018;137:e15-e28.
    PubMed     Abstract available


  130. HSU S, Kokkonen-Simon KM, Kirk JA, Kolb TM, et al
    Right Ventricular Myofilament Functional Differences in Humans with Systemic Sclerosis-associated versus Idiopathic Pulmonary Arterial Hypertension.
    Circulation. 2018 Jan 19. pii: CIRCULATIONAHA.117.033147.
    PubMed     Abstract available


  131. JACKSON SL, Cogswell ME, Zhao L, Terry AL, et al
    Association Between Urinary Sodium and Potassium Excretion and Blood Pressure Among Adults in the United States: National Health and Nutrition Examination Survey, 2014.
    Circulation. 2018;137:237-246.
    PubMed     Abstract available


  132. ZANCHETTI A, Thomopoulos C
    Benefits and Risks of Antihypertensive Treatment: How Far Can Diastolic Blood Pressure Be Lowered?
    Circulation. 2018;137:144-147.
    PubMed    


  133. MUNTNER P, Carey RM, Gidding S, Jones DW, et al
    Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline.
    Circulation. 2018;137:109-118.
    PubMed     Abstract available


  134. BEDDHU S, Chertow GM, Cheung AK, Cushman WC, et al
    Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control.
    Circulation. 2018;137:134-143.
    PubMed     Abstract available


  135. BOYD HA, Basit S, Wohlfahrt J, Oyen N, et al
    Response by Boyd et al to Letter Regarding Article, "Association Between Fetal Congenital Heart Defects and Maternal Risk of Hypertensive Disorders of Pregnancy in the Same Pregnancy and Across Pregnancies".
    Circulation. 2018;137:97-98.
    PubMed    


  136. YE Z, Su Q, Li L
    Letter by Ye et al Regarding Article, "Association Between Fetal Congenital Heart Defects and Maternal Risk of Hypertensive Disorders of Pregnancy in the Same Pregnancy and Across Pregnancies".
    Circulation. 2018;137:95-96.
    PubMed    


    December 2017
  137. ARCHER SL
    Pyruvate Kinase and Warburg Metabolism in Pulmonary Arterial Hypertension: Uncoupled Glycolysis and the Cancer-Like Phenotype of Pulmonary Arterial Hypertension.
    Circulation. 2017;136:2486-2490.
    PubMed    


  138. PAZOKI R, Dehghan A, Evangelou E, Warren H, et al
    Genetic Predisposition to High Blood Pressure and Lifestyle Factors: Associations with Midlife Blood Pressure Levels and Cardiovascular Events.
    Circulation. 2017 Dec 18. pii: CIRCULATIONAHA.117.030898.
    PubMed     Abstract available


  139. FAYYAZ AU, Edwards WD, Maleszewski JJ, Konik EA, et al
    Global Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated with Heart Failure and Preserved or Reduced Ejection Fraction.
    Circulation. 2017 Dec 15. pii: CIRCULATIONAHA.117.031608.
    PubMed     Abstract available


  140. KALKMAN DN, Brouwer TF, Vehmeijer JT, Berger WR, et al
    J Curve in Patients Randomly Assigned to Different Systolic Blood Pressure Targets: An Experimental Approach to an Observational Paradigm.
    Circulation. 2017;136:2220-2229.
    PubMed     Abstract available


    November 2017
  141. CAILLON A, Huo KG, Paradis P, Schiffrin EL, et al
    Response by Caillon et al to Letter Regarding Article, "gammadelta T Cells Mediate Angiotensin II-Induced Hypertension and Vascular Injury".
    Circulation. 2017;136:2200-2201.
    PubMed    


  142. CAMPBELL DJ
    Letter by Campbell Regarding Article, "gammadelta T Cells Mediate Angiotensin II-Induced Hypertension and Vascular Injury".
    Circulation. 2017;136:2198-2199.
    PubMed    


  143. KOSKINEN J, Juonala M, Dwyer T, Venn A, et al
    Impact of Lipid Measurements in Youth in Addition to Conventional Clinic-Based Risk Factors on Predicting Preclinical Atherosclerosis in Adulthood: The International Childhood Cardiovascular Cohort (i3C) Consortium.
    Circulation. 2017 Nov 23. pii: CIRCULATIONAHA.117.029726.
    PubMed     Abstract available


  144. DA SILVA GONCALVES BOS D, Van Der Bruggen CE, Kurakula K, Sun XQ, et al
    Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
    Circulation. 2017 Nov 22. pii: CIRCULATIONAHA.117.027451.
    PubMed     Abstract available


  145. CULLEY MK, Chan SY
    Human Endogenous Retrovirus K and Pulmonary Arterial Hypertension: A New Take on a Retro Idea.
    Circulation. 2017;136:1936-1938.
    PubMed    


  146. SCHIAVON CA, Bersch-Ferreira AC, Santucci EV, Oliveira JD, et al
    Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension).
    Circulation. 2017 Nov 13. pii: CIRCULATIONAHA.117.032130.
    PubMed     Abstract available


  147. WENG LC, Preis SR, Hulme OL, Larson MG, et al
    Genetic Predisposition, Clinical Risk Factor Burden, and Lifetime Risk of Atrial Fibrillation.
    Circulation. 2017 Nov 12. pii: CIRCULATIONAHA.117.031431.
    PubMed     Abstract available


    October 2017
  148. WEATHERALD J, Boucly A, Chemla D, Savale L, et al
    The Prognostic Value of Follow-up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension.
    Circulation. 2017 Oct 25. pii: CIRCULATIONAHA.117.029254.
    PubMed     Abstract available


  149. LYTVYN Y, Bjornstad P, Udell JA, Lovshin JA, et al
    Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials.
    Circulation. 2017;136:1643-1658.
    PubMed     Abstract available


  150. CARNETHON MR, Pu J, Howard G, Albert MA, et al
    Cardiovascular Health in African Americans: A Scientific Statement From the American Heart Association.
    Circulation. 2017 Oct 23. pii: CIR.0000000000000534.
    PubMed     Abstract available


    September 2017
  151. HADINNAPOLA C, Bleda M, Haimel M, Screaton N, et al
    Phenotypic Characterisation of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically with Pulmonary Arterial Hypertension.
    Circulation. 2017 Sep 28. pii: CIRCULATIONAHA.117.028351.
    PubMed     Abstract available


  152. NIIRANEN TJ, Larson MG, McCabe EL, Xanthakis V, et al
    Prognosis of Prehypertension Without Progression to Hypertension.
    Circulation. 2017;136:1262-1264.
    PubMed    


  153. ZHANG H, Wang D, Li M, Plecita-Hlavata L, et al
    The Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension is Regulated through a MiR-124/PTBP1/PKM Axis.
    Circulation. 2017 Sep 26. pii: CIRCULATIONAHA.117.028069.
    PubMed     Abstract available


  154. CARUSO P, Dunmore BJ, Schlosser K, Schoors S, et al
    Identification of miR-124 as a Major Regulator of Enhanced Endothelial Cell Glycolysis in Pulmonary Arterial Hypertension via PTBP1 and PKM2.
    Circulation. 2017 Sep 26. pii: CIRCULATIONAHA.117.028034.
    PubMed     Abstract available


  155. SAITO T, Miyagawa K, Chen SY, Tamosiuniene R, et al
    Upregulation of HERV-K is Linked to Immunity and Inflammation in Pulmonary Arterial Hypertension.
    Circulation. 2017 Sep 21. pii: CIRCULATIONAHA.117.027589.
    PubMed     Abstract available


  156. HUANG C, Moran AE, Coxson PG, Yang X, et al
    Potential Cardiovascular and Total Mortality Benefits of Air Pollution Control in Urban China.
    Circulation. 2017 Sep 7. pii: CIRCULATIONAHA.116.026487.
    PubMed     Abstract available


    August 2017
  157. LI H, Cai J, Chen R, Zhao Z, et al
    Particulate Matter Exposure and Stress Hormone Levels: A Randomized, Double-Blind, Crossover Trial of Air Purification.
    Circulation. 2017;136:618-627.
    PubMed     Abstract available


  158. LAU DH, Nattel S, Kalman JM, Sanders P, et al
    Modifiable Risk Factors and Atrial Fibrillation.
    Circulation. 2017;136:583-596.
    PubMed     Abstract available



  159. Correction to: Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).
    Circulation. 2017;136:e136.
    PubMed    


    July 2017
  160. AHMAD FS, Chan C, Rosenman MB, Post WS, et al
    Validity of Cardiovascular Data From Electronic Sources:The Multi-Ethnic Study of Atherosclerosis and HealthLNK.
    Circulation. 2017 Jul 7. pii: CIRCULATIONAHA.117.027436.
    PubMed     Abstract available


    June 2017
  161. STERGIOU GS, Ntineri A, Kollias A
    Defining Ambulatory Blood Pressure Thresholds for Decision Making in Hypertension: The Effect of Race and Methodology.
    Circulation. 2017;135:2481-2484.
    PubMed    


  162. RAVENELL J, Shimbo D, Booth JN 3rd, Sarpong DF, et al
    Thresholds for Ambulatory Blood Pressure Among African Americans in the Jackson Heart Study.
    Circulation. 2017;135:2470-2480.
    PubMed     Abstract available


  163. TAJEU GS, Booth JN 3rd, Colantonio LD, Gottesman RF, et al
    Incident Cardiovascular Disease Among Adults with Blood Pressure < 140/90 mm Hg.
    Circulation. 2017 Jun 20. pii: CIRCULATIONAHA.117.027362.
    PubMed     Abstract available


  164. MCEVOY JW, Blaha MJ
    Response by McEvoy and Blaha to Letter Regarding Article, "Coronary Artery Calcium to Guide a Personalized Risk-Based Approach to Initiation and Intensification of Antihypertensive Therapy".
    Circulation. 2017;135:e1113-e1114.
    PubMed    


  165. HARBAOUI B, Courand PY, Lantelme P
    Letter by Harbaoui et al Regarding Article, "Coronary Artery Calcium to Guide a Personalized Risk-Based Approach to Initiation and Intensification of Antihypertensive Therapy".
    Circulation. 2017;135:e1111-e1112.
    PubMed    


    May 2017
  166. SAG CM, Schnelle M, Zhang J, Murdoch CE, et al
    Distinct Regulatory Effects of Myeloid Cell and Endothelial Cell NAPDH Oxidase 2 on Blood Pressure.
    Circulation. 2017;135:2163-2177.
    PubMed     Abstract available


  167. DAVIS J
    Putting the Brakes on Hypertensive Remodeling: An ATF3 Mechanism of Myofibroblast Restraint.
    Circulation. 2017;135:2058-2061.
    PubMed    


  168. SOLIMAN EZ, Ambrosius WT, Cushman WC, Zhang ZM, et al
    Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients with Hypertension: The Systolic Blood Pressure Intervention (SPRINT) Trial.
    Circulation. 2017 May 16. pii: CIRCULATIONAHA.117.028441.
    PubMed     Abstract available


    April 2017
  169. AUBDOOL AA, Thakore P, Argunhan F, Smillie SJ, et al
    A Novel alpha-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy and Heart Failure.
    Circulation. 2017 Apr 26. pii: CIRCULATIONAHA.117.028388.
    PubMed     Abstract available


  170. PHILLIPS RA
    Hypertension Treatment and Outcomes in the Era of Population Health, Coordinated Care, and Medicare Access and CHIP Reauthorization Act (MACRA).
    Circulation. 2017;135:1629-1631.
    PubMed    


  171. BRESS AP, Kramer H, Khatib R, Beddhu S, et al
    Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examina
    Circulation. 2017;135:1617-1628.
    PubMed     Abstract available


  172. BOYD HA, Basit S, Behrens I, Leirgul E, et al
    Association Between Fetal Congenital Heart Defects and Maternal Risk of Hypertensive Disorders of Pregnancy in the Same Pregnancy and Across Pregnancies.
    Circulation. 2017 Apr 19. pii: CIRCULATIONAHA.116.024600.
    PubMed     Abstract available


    March 2017
  173. HWANGBO C, Lee HW, Kang H, Ju H, et al
    Modulation of Endothelial BMPR2 Activity by VEGFR3 in Pulmonary Arterial Hypertension.
    Circulation. 2017 Mar 29. pii: CIRCULATIONAHA.116.025390.
    PubMed     Abstract available


  174. CAILLON A, Mian MO, Fraulob-Aquino JC, Huo KG, et al
    Gamma Delta T Cells Mediate Angiotensin II-Induced Hypertension and Vascular Injury.
    Circulation. 2017 Mar 22. pii: CIRCULATIONAHA.116.027058.
    PubMed     Abstract available


  175. LI Y, Li Z, Zhang C, Li P, et al
    Cardiac Fibroblast-Specific Activating Transcription Factor 3 Protects Against Heart Failure by Suppressing MAP2K3-p38 Signaling.
    Circulation. 2017 Mar 1. pii: CIRCULATIONAHA.116.024599.
    PubMed     Abstract available


    January 2017
  176. LA GERCHE A, Brosnan MJ
    Cardiovascular Effects of Performance-Enhancing Drugs.
    Circulation. 2017;135:89-99.
    PubMed     Abstract available


    November 2016
  177. MAHMOODI BK, Cushman M, Naess IA, Allison MA, et al
    Association of Traditional Cardiovascular Risk Factors with Venous Thromboembolism: An Individual Participant Data Meta-analysis of Prospective Studies.
    Circulation. 2016 Nov 9. pii: CIRCULATIONAHA.116.024507.
    PubMed     Abstract available


  178. WALSH KB, Woo D, Sekar P, Osborne J, et al
    Untreated Hypertension: A Powerful Risk Factor for Lobar and Nonlobar Intracerebral Hemorrhage in Whites, Blacks, and Hispanics.
    Circulation. 2016;134:1444-1452.
    PubMed     Abstract available


  179. ST-ONGE MP, Grandner MA, Brown D, Conroy MB, et al
    Sleep Duration and Quality: Impact on Lifestyle Behaviors and Cardiometabolic Health: A Scientific Statement From the American Heart Association.
    Circulation. 2016;134:e367-e386.
    PubMed     Abstract available


    October 2016
  180. BOZKURT B, Aguilar D, Deswal A, Dunbar SB, et al
    Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Oct 31. pii: CIR.0000000000000450.
    PubMed    


    August 2016
  181. VOS MB, Kaar JL, Welsh JA, Van Horn LV, et al
    Added Sugars and Cardiovascular Disease Risk in Children: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Aug 22. pii: CIR.0000000000000439.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: